These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 29754534)

  • 21. Parental attitudes to the identification of their infants as carriers of cystic fibrosis by newborn screening.
    Lewis S; Curnow L; Ross M; Massie J
    J Paediatr Child Health; 2006 Sep; 42(9):533-7. PubMed ID: 16925540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Public reaction to direct-to-consumer online genetic tests: Comparing attitudes, trust and intentions across commercial and conventional providers.
    Critchley C; Nicol D; Otlowski M; Chalmers D
    Public Underst Sci; 2015 Aug; 24(6):731-50. PubMed ID: 24553439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cascade carrier-testing in cystic fibrosis.
    Roberts T; Schwarz MJ; Kerr-Liddell R; Hinks JL; Super M
    Paediatr Respir Rev; 2003 Dec; 4(4):293-8. PubMed ID: 14629951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluating online direct-to-consumer marketing of genetic tests: informed choices or buyers beware?
    Geransar R; Einsiedel E
    Genet Test; 2008 Mar; 12(1):13-23. PubMed ID: 18373401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cystic fibrosis carrier screening practices in an ethnically diverse region: experience of the Genetic Network of the Empire State, Puerto Rico, and the U.S. Virgin Islands.
    Schwind EL; Wolfe M; Greendale K; Misra LM; Pass KA; Wallerstein R
    Genet Test; 1999; 3(2):215-8. PubMed ID: 10464670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cystic fibrosis carrier screening: knowledge and attitudes of prenatal care providers.
    Rowley PT; Loader S; Levenkron JC; Phelps CE
    Am J Prev Med; 1993; 9(5):261-6. PubMed ID: 8257614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct-to-Consumer Genetic Testing Data Privacy: Key Concerns and Recommendations Based on Consumer Perspectives.
    Hendricks-Sturrup RM; Lu CY
    J Pers Med; 2019 May; 9(2):. PubMed ID: 31075859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carrier testing program in a high-risk cystic fibrosis population from northeastern Italy. Active recruitment of relatives via probands' parents.
    Borgo G; Castellani C; Bonizzato A; Rolfini R; Altieri S; Zanolla L; Mastella G
    Community Genet; 1999; 2(2-3):82-90. PubMed ID: 15181338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A 10-year large-scale cystic fibrosis carrier screening in the Italian population.
    Picci L; Cameran M; Marangon O; Marzenta D; Ferrari S; Frigo AC; Scarpa M
    J Cyst Fibros; 2010 Jan; 9(1):29-35. PubMed ID: 19897426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Community-wide screening for cystic fibrosis carriers could replace newborn screening for the diagnosis of cystic fibrosis.
    Massie J; Forbes R; Dusart D; Bankier A; Delatycki MB
    J Paediatr Child Health; 2007 Nov; 43(11):721-3. PubMed ID: 17924936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. General practitioner attitudes to direct-to-consumer genetic testing in New Zealand.
    Ram S; Russell B; Gubb M; Taylor R; Butler C; Khan I; Shelling A
    N Z Med J; 2012 Oct; 125(1364):14-26. PubMed ID: 23242394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The views of general practitioners on community carrier screening for cystic fibrosis.
    Boulton M; Cummings C; Williamson R
    Br J Gen Pract; 1996 May; 46(406):299-301. PubMed ID: 8762747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Respiratory physicians and clinic coordinators' attitudes to population-based cystic fibrosis carrier screening.
    Cunningham F; Lewis S; Curnow L; Glazner J; Massie J
    J Cyst Fibros; 2014 Jan; 13(1):99-105. PubMed ID: 23891279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changing their minds with time: a comparison of hypothetical and actual reproductive behaviors in parents of children with cystic fibrosis.
    Sawyer SM; Cerritelli B; Carter LS; Cooke M; Glazner JA; Massie J
    Pediatrics; 2006 Sep; 118(3):e649-56. PubMed ID: 16950956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct-to-Consumer Tests on the Market Today: Identifying Valuable Tests from Those with Limited Utility.
    Isbell TS
    Clin Lab Med; 2020 Mar; 40(1):13-23. PubMed ID: 32008636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Australians' knowledge and perceptions of direct-to-consumer personal genome testing.
    Savard J; Mooney-Somers J; Newson AJ; Kerridge I
    Intern Med J; 2014 Jan; 44(1):27-31. PubMed ID: 24450520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. To know or not to know, disclosure of a newborn carrier screening test result for cystic fibrosis.
    Vernooij-van Langen AM; Reijntjens S; van der Pal SM; Loeber JG; Dompeling E; Dankert-Roelse JE
    Eur J Med Genet; 2013 Apr; 56(4):192-6. PubMed ID: 23352994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Preconceptional carrier screening should not be delayed].
    Cornel MC; Lakeman P; Dondorp W
    Ned Tijdschr Geneeskd; 2011; 155():A3205. PubMed ID: 21504638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Update on population-based preconception and prenatal cystic fibrosis carrier screening.
    Nolen AA; Rhoades ED
    J Okla State Med Assoc; 2003 Oct; 96(10):482-4. PubMed ID: 14619603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population-based carrier screening for cystic fibrosis in Victoria: the first three years experience.
    Massie J; Petrou V; Forbes R; Curnow L; Ioannou L; Dusart D; Bankier A; Delatycki M
    Aust N Z J Obstet Gynaecol; 2009 Oct; 49(5):484-9. PubMed ID: 19780730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.